Sign in

Justin Strickland

@juststrickland.bsky.social
245 followers 218 following 1 posts

Behavioral Pharmacologist/Associate Professor at Hopkins SoM and Recreational Scurrier (he/him)

PostsRepliesMedia
Reposted by Justin Strickland
Jeremy Hogeveen @jeremyhogeveen.bsky.social · 26/08/2025
Katz has been a game changer for me and my lab, so happy to see it reissued!
0206 0
Reposted by Justin Strickland
Johannes Thrul @drjthrul.bsky.social · 14/07/2025
1/5 New paper on medicinal cannabis: We followed adults with clinically significant anxiety & depression who were new to medicinal cannabis using 8 weeks of EMA and 6 months of longitudinal follow up and saw significant and clinically meaningful benefits. authors.elsevier.com/c/1lQBfbXYiy...
1115 0
Justin Strickland @juststrickland.bsky.social · 09/06/2025
Excited to join the team over at UMB this December!
0101 0
Reposted by Justin Strickland
Jibran Khokhar @drjkhokhar.bsky.social · 03/06/2025
The 2025 GRC on Cannabinoid Function in the CNS: Cannabinoid Neurobiology: Bridging Basic Science, Big Data, Biomarkers and Bedside Applications Across the Lifespan final program is here! Spots are going fast! Register soon for trainee talks! Reshare please! grc.org/cannabinoid-...
0167 0
Reposted by Justin Strickland
Eric Pedersen @ericrpedersen.bsky.social · 08/04/2025
We made a mock #cannabis dispensary for @iasatusc.bsky.social to use for research. Check out a detailed description of how we did it, including interviews w/ dispensary staff and our plan for stocking with product packaging. @uscpsychiatry.bsky.social publications.sciences.ucf.edu/cannabis/ind...
1299 0
Reposted by Justin Strickland
European Behavioural Pharmacology Society @eurbehavpharm.bsky.social · 04/04/2025
Our second parallel session features this first symposium explores the various effects of manipulating the dopamine transporter system and highlights the therapeutic potential of these manipulations chaired by @mercecorrea.bsky.social. #EBPS2025
142 0
Reposted by Justin Strickland
European Behavioural Pharmacology Society @eurbehavpharm.bsky.social · 04/04/2025
Finally, our third symposium in this parallel session, chaired by @juststrickland.bsky.social , explores cognitive and computational approaches to behaviour in substance use and related conditions. #EBPS2025
052 0
Reposted by Justin Strickland
APA Division 50 Society of Addiction Psychology @apadivision50.bsky.social · 31/03/2025
We want to follow #CPA2025 attendees. Will we be seeing you in PVD this week? Like this post and we’ll be sure to follow.
1314 0
Reposted by Justin Strickland
Patrick Mulholland (He/Him) @mulhollandlab.bsky.social · 20/03/2025
The Charleston Alcohol Research Center has an opening for a #postdoctoral fellowship on the #NIAAA T32 training grant - please spread the word and contact me if interested in working in beautiful Charleston, SC @drjrink.bsky.social
023 0
Reposted by Justin Strickland
Jeremy Hogeveen @jeremyhogeveen.bsky.social · 03/03/2025
Importantly, Ethan is on the postdoc market at the moment! He's learned *A TON* of skills during his grad training (EEG, FMRI, fMRI-guided TBS, and computational modeling) and I think he will make an excellent postdoc. Let me know if you are looking for someone!
164 0
Reposted by Justin Strickland
Stephanie Borgland @borglandlab.bsky.social · 03/02/2025
Work from Nada Sallam showing prenatal cannabis exposure influences glycemic control in female mice and their response to high fat diet exposure. doi.org/10.1111/bph....
doi.org
BPS Publications
Sex differences in the effects of maternal voluntary editable Cannabis consumption on the metabolic phenotype of adult offspring on a high-fat diet.
085 0
Reposted by Justin Strickland
Leah Mayo @mayoonthebrain.bsky.social · 22/01/2025
The first @pact-lab.bsky.social paper of 2025 is out now in @npp-journal.bsky.social 🤩 Led by @madeleinejones.bsky.social & @connorhaggarty.bsky.social ft. @abby-lunge.bsky.social @cannabrain.bsky.social & others www.nature.com/articles/s41...
nature.com
Endocannabinoid contributions to the perception of socially relevant, affective touch in humans - Neuropsychopharmacology
Neuropsychopharmacology - Endocannabinoid contributions to the perception of socially relevant, affective touch in humans
14617 0
Reposted by Justin Strickland
Jonas Dora @jonasdora.bsky.social · 14/01/2025
I'm excited to share a new preprint: In a novel experimental paradigm, we found evidence that stress induces a computational bias during alcohol-related decision-making in favor of alcohol, but this bias was only sometimes strong enough to overcome competing considerations (e.g., taste preferences).
34124 0
Reposted by Justin Strickland
Colette Delawalla, PhD @cdelawalla.bsky.social · 24/12/2024
Merry Christmas and Happy Hanukkah from @lluaces.bsky.social and I! “Informed” consent? Ethical considerations for clinicians using therapy-matching platforms. psycnet.apa.org/record/2025-...
psycnet.apa.org
APA PsycNet
2224 0
Reposted by Justin Strickland
Journal of Studies on Alcohol and Drugs @jsadjournal.bsky.social · 17/12/2024
Efficiently Quantifying Egocentric Social Network Cannabis Use: Initial Psychometric Validation of the Brief Cannabis Social ... (new @jsadjournal.bsky.social) @samuelacuff.bsky.social @juststrickland.bsky.social @addpsychpodcast.bsky.social @james-g-murphy.bsky.social www.jsad.com/doi/full/10....
jsad.com
Efficiently Quantifying Egocentric Social Network Cannabis Use: Initial Psychometric Validation of the Brief Cannabis Social Density Assessment: Journal of Studies on Alcohol and Drugs: Vol 85, No 6
Objective: Social environment is a key determinant of substance use, but cannabis-related social network analysis is not common, in part because of the assessment burden of comprehensive egocentric social network analysis. Method: The current pre-registered secondary analysis assessed the psychometric properties (i.e., convergent, criterion-related, incremental validity) of the Brief Cannabis Social Density Assessment (B-CaSDA) in a cross-sectional sample of adults who use cannabis (N = 310) using a survey-based design. The B-CaSDA assesses the quantity and frequency of cannabis use for the respondent's four closest (nonparent) relationships. Results: Ego cannabis use severity was elevated for each additional person who used cannabis at all or daily in the individual's social network. B-CaSDA indices (i.e., frequency, quantity, total score) were positively correlated with cannabis consumption, cannabis use severity indicators, and established risk factors for harmful cannabis use. B-CaSDA indices also discriminated between those above and below a clinical cutoff on the Cannabis Use Disorder Identification Test–Revised (CUDIT-R). Finally, in omnibus models that included common risk factors for cannabis use severity, the B-CaSDA quantity index contributed additional variance when predicting CUDIT-R total score, and B-CaSDA frequency contributed additional variance in predicting the CUDIT-R quantity–frequency subscale. Conclusions: The results suggest that the B-CaSDA has the potential to expand social network research on cannabis use and misuse by increasing its assessment feasibility in diverse designs.
062 0